[{"address1": "4149 Liberty Canyon Road", "city": "Agoura Hills", "state": "CA", "zip": "91301", "country": "United States", "phone": "805 730 0360", "website": "https://www.acelyrin.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is izokibep, a small protein therapeutic designed to inhibit IL-17A with high potency, which is in Phase 3 clinical trials for use in the treatment of Hidradenitis Suppurativa, Psoriatic Arthritis, and uveitis, as well as in Phase 2 clinical trials for use in the treatment of Axial Spondyloarthritis. It is also developing lonigutamab, a humanized immunoglobulin G1 (IgG1) monoclonal antibody which is in Phase 1 clinical trials for use in the treatment of thyroid eye disease. In addition, the company's develops SLRN-517, a fully human IgG1 monoclonal antibody targeting c-KIT, which is in preclinical stage for use in the treatment of chronic urticaria. Acelyrin, Inc. was incorporated in 2020 and is headquartered in Agoura Hills, California.", "fullTimeEmployees": 135, "companyOfficers": [{"maxAge": 1, "name": "Ms. Mina  Kim J.D.", "age": 50, "title": "CEO & Director", "yearBorn": 1974, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tyler  Marciniak", "title": "Vice President of Investor Relations, Communications & Corporate Operations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. K. Amar Murugan J.D.", "age": 48, "title": "Chief Legal Officer", "yearBorn": 1976, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kelly  Chow", "title": "Chief People Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kenneth A. Lock", "age": 50, "title": "Chief Commercial Officer", "yearBorn": 1974, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shephard  Mpofu M.D.", "title": "Chief Medical Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Patricia A. Turney", "age": 57, "title": "Chief Technical Operations Officer", "yearBorn": 1967, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 4, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1738368000, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.56, "open": 2.57, "dayLow": 2.56, "dayHigh": 2.71, "regularMarketPreviousClose": 2.56, "regularMarketOpen": 2.57, "regularMarketDayLow": 2.56, "regularMarketDayHigh": 2.71, "payoutRatio": 0.0, "forwardPE": -1.2641511, "volume": 1622182, "regularMarketVolume": 1621323, "averageVolume": 2118335, "averageVolume10days": 4188560, "averageDailyVolume10Day": 4188560, "bid": 2.65, "ask": 2.7, "bidSize": 38, "askSize": 26, "marketCap": 268873696, "fiftyTwoWeekLow": 1.845, "fiftyTwoWeekHigh": 8.76, "fiftyDayAverage": 2.4608, "twoHundredDayAverage": 4.353125, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -286118464, "profitMargins": 0.0, "floatShares": 72214345, "sharesOutstanding": 100326000, "sharesShort": 4715987, "sharesShortPriorMonth": 6526582, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.047, "heldPercentInsiders": 0.088199995, "heldPercentInstitutions": 1.06941, "shortRatio": 2.1, "shortPercentOfFloat": 0.053600002, "impliedSharesOutstanding": 100326000, "bookValue": 5.286, "priceToBook": 0.5069997, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -264404992, "trailingEps": -2.46, "forwardEps": -2.12, "enterpriseToEbitda": 0.767, "52WeekChange": -0.6893204, "SandP52WeekChange": 0.16050637, "quoteType": "EQUITY", "currentPrice": 2.68, "targetHighPrice": 20.0, "targetLowPrice": 8.0, "targetMeanPrice": 14.0, "targetMedianPrice": 14.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 562372992, "totalCashPerShare": 5.605, "ebitda": -373011008, "totalDebt": 7382000, "quickRatio": 7.098, "currentRatio": 7.147, "debtToEquity": 1.397, "returnOnAssets": -0.32891998, "returnOnEquity": -0.41946998, "freeCashflow": -192560000, "operatingCashflow": -255968992, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SLRN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NMS", "messageBoardId": "finmb_698766339", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "ACELYRIN, INC.", "longName": "Acelyrin, Inc.", "regularMarketChangePercent": 4.687505, "regularMarketPrice": 2.68, "postMarketChangePercent": 0.0, "postMarketPrice": 2.68, "postMarketChange": 0.0, "regularMarketChange": 0.120000124, "regularMarketDayRange": "2.56 - 2.71", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2118335, "corporateActions": [], "postMarketTime": 1740786445, "regularMarketTime": 1740776401, "marketState": "CLOSED", "fiftyTwoWeekLowChange": 0.83500004, "fiftyTwoWeekLowChangePercent": 0.45257455, "fiftyTwoWeekRange": "1.845 - 8.76", "fiftyTwoWeekHighChange": -6.08, "fiftyTwoWeekHighChangePercent": -0.6940639, "fiftyTwoWeekChangePercent": -68.93204, "earningsTimestampStart": 1743192000, "earningsTimestampEnd": 1743883200, "earningsCallTimestampStart": 1731533400, "earningsCallTimestampEnd": 1731533400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.46, "epsForward": -2.12, "epsCurrentYear": -2.43, "priceEpsCurrentYear": -1.1028806, "fiftyDayAverageChange": 0.21920013, "fiftyDayAverageChangePercent": 0.08907678, "twoHundredDayAverageChange": -1.673125, "twoHundredDayAverageChangePercent": -0.38435033, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-05-05", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1683207000000, "displayName": "Acelyrin", "trailingPegRatio": null, "__fetch_time": "2025-03-01"}]